Editorial: Biological and non-pharmacological treatments of obsessive-compulsive disorder and related disorders.
作者信息
de Filippis Renato, El Hayek Samer, Shalbafan Mohammadreza
机构信息
Psychiatry Unit, Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy.
Medical Department, Erada Center for Treatment and Rehabilitation in Dubai, Dubai, United Arab Emirates.
出版信息
Front Psychiatry. 2024 Oct 22;15:1494444. doi: 10.3389/fpsyt.2024.1494444. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Biological and non-pharmacological treatments of obsessive-compulsive disorder and related disorders.社论：强迫症及相关障碍的生物学和非药物治疗
Front Psychiatry. 2024 Oct 22;15:1494444. doi: 10.3389/fpsyt.2024.1494444. eCollection 2024.
2
Deep brain stimulation in obsessive-compulsive disorder.强迫症的深部脑刺激疗法
Prog Brain Res. 2009;175:419-27. doi: 10.1016/S0079-6123(09)17527-1.
3
Deep brain stimulation in obsessive-compulsive disorder: Results from meta-analysis.深部脑刺激治疗强迫症：荟萃分析结果。
Psychiatry Res. 2022 Nov;317:114869. doi: 10.1016/j.psychres.2022.114869. Epub 2022 Sep 28.
4
Deep brain stimulation for treatment-refractory obsessive-compulsive disorder should be an accepted therapy in Australia.在澳大利亚，深部脑刺激术治疗难治性强迫症应成为一种被认可的疗法。
Aust N Z J Psychiatry. 2022 May;56(5):430-436. doi: 10.1177/00048674211031482. Epub 2021 Jul 15.
5
Deep brain stimulation for treatment-refractory obsessive compulsive disorder: a systematic review.深部脑刺激治疗难治性强迫症：一项系统评价。
BMC Psychiatry. 2014 Aug 2;14:214. doi: 10.1186/s12888-014-0214-y.
6
Deep brain stimulation for severe treatment-resistant obsessive-compulsive disorder: An open-label case series.深部脑刺激治疗严重治疗抵抗性强迫症：一项开放性病例系列研究。
Aust N Z J Psychiatry. 2018 Jul;52(7):699-708. doi: 10.1177/0004867417731819. Epub 2017 Sep 30.
7
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part II: OCD and PTSD.世界生物精神病学协会联盟（WFSBP）焦虑症、强迫症及创伤后应激障碍治疗指南 - 第3版。第二部分：强迫症与创伤后应激障碍。
World J Biol Psychiatry. 2023 Feb;24(2):118-134. doi: 10.1080/15622975.2022.2086296. Epub 2022 Jul 28.
8
Deep-brain stimulation in treatment-resistant obsessive-compulsive disorder: Clinical and molecular neuroimaging correlation.深部脑刺激治疗难治性强迫症：临床与分子神经影像学相关性
Rev Colomb Psiquiatr (Engl Ed). 2020 Jan-Mar;49(1):62-65. doi: 10.1016/j.rcp.2018.05.002. Epub 2018 Jul 9.
9
Experimental therapeutics for refractory obsessive-compulsive disorder: translational approaches and new somatic developments.难治性强迫症的实验性治疗：转化方法与新的躯体治疗进展
Mt Sinai J Med. 2008 May-Jun;75(3):174-203. doi: 10.1002/msj.20045.
10
Inferior thalamic peduncle deep brain stimulation for treatment-refractory obsessive-compulsive disorder: A phase 1 pilot trial.丘脑下脚深部脑刺激治疗难治性强迫症的 1 期初步试验。
Brain Stimul. 2019 Mar-Apr;12(2):344-352. doi: 10.1016/j.brs.2018.11.012. Epub 2018 Nov 27.
本文引用的文献
1
Obsessive-Compulsive Disorder as an Epiphenomenon of Comorbid Bipolar Disorder? An Updated Systematic Review.强迫症作为双相情感障碍共病的一种附带现象？一项最新的系统评价。
J Clin Med. 2024 Feb 21;13(5):1230. doi: 10.3390/jcm13051230.
2
Brain stimulation and other biological non-pharmacological interventions in mental disorders: An umbrella review.脑刺激和其他生物非药物干预在精神障碍中的应用：伞式综述。
Neurosci Biobehav Rev. 2022 Aug;139:104743. doi: 10.1016/j.neubiorev.2022.104743. Epub 2022 Jun 14.
3
Treatment Preferences for Pharmacological versus Psychological Interventions among Primary Care Providers in Nepal: Mixed Methods Analysis of a Pilot Cluster Randomized Controlled Trial.尼泊尔初级保健提供者对药物与心理干预治疗的偏好：一项试点性整群随机对照试验的混合方法分析。
Int J Environ Res Public Health. 2022 Feb 14;19(4):2149. doi: 10.3390/ijerph19042149.
4
Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial.盐酸美金刚联合舍曲林治疗强迫症患者的症状和执行功能：一项双盲安慰剂对照、随机临床试验。
BMC Psychiatry. 2022 Jan 12;22(1):34. doi: 10.1186/s12888-021-03642-z.
5
Glutamatergic medications as adjunctive therapy for moderate to severe obsessive-compulsive disorder in adults: a systematic review and meta-analysis.谷氨酸能药物作为成人中重度强迫症的辅助治疗：系统评价和荟萃分析。
BMC Pharmacol Toxicol. 2021 Nov 4;22(1):69. doi: 10.1186/s40360-021-00534-6.
6
Psychosocial and psychological interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis.精神分裂症复发预防的心理社会和心理干预：系统评价和网络荟萃分析。
Lancet Psychiatry. 2021 Nov;8(11):969-980. doi: 10.1016/S2215-0366(21)00243-1. Epub 2021 Oct 12.
7
Current and emerging long-acting antipsychotics for the treatment of schizophrenia.当前和新兴的长效抗精神病药治疗精神分裂症。
Expert Opin Drug Saf. 2021 Jul;20(7):771-790. doi: 10.1080/14740338.2021.1910674. Epub 2021 Apr 12.
8
Impact of Bipolar Disorder and Obsessive-Compulsive Disorder Comorbidity on Neurocognitive Profile: A Mini-Review.双相情感障碍和强迫症共病对神经认知特征的影响：小型综述。
Psychiatr Danub. 2020 Autumn-Winter;32(3-4):346-350. doi: 10.24869/psyd.2020.346.
9
A systematic review and meta-analysis on the effects of transcranial direct current stimulation in depressive episodes.一项关于经颅直流电刺激对抑郁发作影响的系统评价和荟萃分析。
Depress Anxiety. 2020 Jul;37(7):594-608. doi: 10.1002/da.23004. Epub 2020 Feb 26.
10
Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trial.氟伏沙明联合曲唑酮治疗强迫症患者的随机双盲安慰剂对照临床试验。
J Psychopharmacol. 2019 Nov;33(11):1407-1414. doi: 10.1177/0269881119878177. Epub 2019 Oct 1.
Zotero 插件